6 Programs

  • Second Opinion: Investigators Provide Perspectives on the Current and Future Use of Novel Therapies for Non-Hodgkin Lymphoma

    Explore program
    • June 2026 2.25 ABIM MOC, CME 1h 57min
      • B
      • C
      • M
        Matthew Lunning, MD
      • +1
      Dr Kahl, Dr Flowers, Dr Lunning, Dr Smith
  • What Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Current and Future Role of Antibody-Drug Conjugates in the Management of Breast Cancer

    Explore program
    • June 2026 2.25 ABIM MOC, ABS MOC, CME 2h 0min
      • E
      • H
        Hope S Rugo, MD
      • N
        Nadia Harbeck, MD, PhD
      • +2
      Dr Hamilton, Dr Rugo, Dr Harbeck, Dr Curigliano, Dr Dent